7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 
      
    		                       
      operating activities
    		                       
      net income
    		-112,728,000 -102,291,000 -109,270,000 -90,354,000 -96,668,000 -91,051,000 -98,669,000 142,797,000 -96,088,000 -82,776,000 -96,460,000 -38,349,000 -109,575,000 -71,950,000 -69,214,000 -64,707,000 -28,118,000 -76,253,000 -201,560,000 -95,464,000 -34,452,000 -34,218,000 -30,458,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                       
      depreciation and amortization
    		5,560,000 5,538,000 5,528,000 5,443,000 5,475,000 5,576,000 5,431,000 5,362,000 5,187,000 4,816,000 4,647,000 3,944,000 3,473,000 3,418,000 3,312,000 2,634,000 1,750,000 1,669,000 1,398,000     
      amortization of investment discount
    		-4,233,000 -4,618,000 -3,849,000 -4,640,000 -5,623,000 -5,926,000 -6,576,000  -7,884,000 -7,573,000 -6,932,000 -5,102,000 -3,217,000 -701,000 -390,000 -47,000 -25,000 -18,000 15,000 69,000    
      in-process research and development charge
    		               0 0 0 154,953,000     
      stock-based compensation expense
    		22,747,000 24,367,000 26,682,000 30,218,000 29,559,000 31,604,000 29,281,000 22,617,000 25,835,000 26,278,000 23,917,000 22,499,000 22,209,000 21,578,000 18,035,000 15,502,000 12,968,000 10,452,000 4,648,000 6,807,000 3,012,000 2,769,000 2,792,000 
      change in operating lease right-of-use assets
    		2,573,000 2,648,000 2,649,000  2,438,000 2,394,000 2,361,000 2,402,000 2,288,000 2,475,000 2,354,000 2,193,000 2,143,000 2,097,000 1,997,000 2,209,000 2,147,000 2,275,000 2,359,000 1,672,000 1,080,000 1,033,000 952,000 
      change in fair value of derivative liabilities
    		2,757,000 -1,147,000 -2,260,000 128,000 200,000 -5,500,000 2,900,000 1,900,000 -4,700,000 900,000 -5,600,000 -3,000,000 4,900,000 -12,200,000 -13,600,000 -7,400,000 -35,800,000 42,300,000 1,900,000 54,700,000 -2,700,000 8,700,000 2,700,000 
      change in fair value of contingent consideration liabilities
    		-1,000,000 28,000 27,000 27,000 27,000 -1,779,000 133,000 -1,863,000 -6,002,000 -2,171,000 296,000 -19,447,000 875,000 120,000 -452,000 4,407,000 -10,599,000 741,000 305,000     
      change in fair value of non-controlling equity investments
    		-4,937,000 -4,415,000 2,081,000 1,090,000 2,064,000 7,586,000 3,353,000 722,000 11,221,000 -6,148,000 12,797,000 -21,578,000 -10,431,000 4,124,000 7,685,000 4,270,000 4,892,000       
      realized gain on sale of marketable securities
    		                       
      changes in operating assets and liabilities:
    		                       
      prepaid expenses and other current assets
    		1,625,000 2,778,000 49,000 -7,807,000 1,744,000 6,246,000 -5,532,000 3,570,000 -3,567,000 1,929,000 -8,405,000 -561,000 -235,000 2,228,000 -9,185,000 13,000 3,839,000 -741,000 -2,365,000 -2,059,000 548,000 -656,000 -3,559,000 
      accounts payable
    		-1,589,000 2,642,000 3,793,000 -550,000 -700,000 1,772,000 1,285,000 -1,768,000 -3,045,000 -2,534,000 -231,000 2,900,000 623,000 102,000 -1,252,000 2,159,000 -1,723,000 1,048,000 -666,000 194,000 -81,000 418,000 -471,000 
      accrued expenses and other liabilities
    		1,977,000 9,868,000 -18,458,000 -4,075,000 -9,849,000 -19,486,000 -24,275,000 70,401,000 7,416,000 -266,000 -9,888,000 8,443,000 3,938,000 -12,781,000 -16,533,000 41,096,000 1,171,000 6,105,000 -4,458,000 2,816,000 4,458,000 -617,000 378,000 
      operating lease liabilities
    		-3,383,000 -3,325,000 -3,297,000 -3,275,000 -3,435,000 -3,133,000 -3,108,000 -3,007,000 -3,107,000 -1,504,000 -2,550,000 -1,066,000 1,151,000 14,125,000 -1,780,000 820,000 3,320,000 5,777,000 6,111,000 6,400,000 -1,448,000 -922,000 -879,000 
      deferred revenue
    		-5,661,000 -8,466,000 -7,470,000 -5,067,000 -13,269,000 -11,272,000 -6,910,000 -99,543,000 -17,192,000 -19,116,000 -23,708,000 -20,037,000 -15,799,000 8,348,000 -8,432,000 298,932,000 -764,000       
      other long-term liabilities
    		-93,000 -57,000 -89,000 22,000 -88,000 -40,000 579,000 -1,017,000 -146,000 1,021,000 -52,000 -30,000 -51,000 -10,784,000 8,296,000 1,942,000 -51,000 -45,000 -57,000 -1,094,000 2,087,000 -6,000 -6,000 
      net cash from operating activities
    		-81,479,000 -76,450,000 -103,884,000 -76,365,000 -88,125,000 -83,009,000 -99,747,000 135,073,000 -89,784,000 -84,669,000 -109,815,000 -69,191,000 -74,496,000 -52,276,000 218,490,000 1,830,000 3,007,000 -32,527,000 -38,578,000 -24,298,000 -21,213,000 -22,837,000 -27,393,000 
      capex
    		-5,011,000 -3,136,000 -3,065,000 -2,970,000 -1,577,000 -1,961,000 -2,438,000 -3,589,000 -7,948,000 -16,178,000 -6,017,000 -8,261,000 -11,787,000 -21,644,000 -7,259,000 -13,369,000 -5,780,000 -16,184,000 -11,478,000 -8,125,000 -2,819,000 -2,367,000 -3,046,000 
      free cash flows
    		-86,490,000 -79,586,000 -106,949,000 -79,335,000 -89,702,000 -84,970,000 -102,185,000 131,484,000 -97,732,000 -100,847,000 -115,832,000 -77,452,000 -86,283,000 -73,920,000 211,231,000 -11,539,000 -2,773,000 -48,711,000 -50,056,000 -32,423,000 -24,032,000 -25,204,000 -30,439,000 
      investing activities
    		                       
      purchases of property and equipment
    		-5,011,000 -3,136,000 -3,065,000 -2,970,000 -1,577,000 -1,961,000 -2,438,000 -3,589,000 -7,948,000 -16,178,000 -6,017,000 -8,261,000 -11,787,000 -21,644,000 -7,259,000 -13,369,000 -5,780,000 -16,184,000 -11,478,000 -8,125,000 -2,819,000 -2,367,000 -3,046,000 
      purchases of marketable securities
    		-175,643,000 -333,942,000 -339,169,000 0 -156,725,000 -134,473,000 -195,241,000 -53,272,000 -273,707,000 -390,827,000 -266,532,000 -238,390,000 -358,031,000 -330,188,000 -690,390,000 -170,477,000 -178,500,000 -139,028,000 -289,218,000 -114,518,000 -31,135,000 -18,240,000 -117,719,000 
      maturities of marketable securities
    		240,644,000 166,667,000 217,145,000 129,250,000 183,000,000 223,927,000 144,215,000 154,960,000 271,425,000 365,525,000 298,000,000 360,090,000 333,644,000 350,570,000 160,310,000 106,350,000 260,395,000 142,075,000 20,450,000 41,216,000 69,182,000 43,475,000 44,723,000 
      proceeds from sale of marketable securities
    		                       
      cash paid for acquisition
    		                       
      net cash from investing activities
    		65,655,000 -170,411,000 -125,089,000 126,280,000 24,698,000 87,493,000 -53,464,000 98,099,000 -10,230,000 -41,480,000 25,451,000 113,439,000 -36,174,000 -1,262,000 -537,339,000 -77,496,000 76,115,000 -13,137,000 -279,626,000 -81,427,000 35,228,000 22,868,000 -76,792,000 
      financing activities
    		                       
      proceeds from issuance of common shares and pre-funded warrants, net of issuance costs
    		0 -646,000 471,159,000                     
      proceeds from issuances of stock under espp
    		1,263,000 0 1,501,000 -1,000 1,224,000 0 1,398,000 0 1,324,000 0 1,708,000 -1,000 1,664,000 0 1,412,000         
      repayment of equipment financings
    		    -201,000 -107,000 -177,000  -400,000 -617,000 -603,000 -590,000 -579,000 -565,000 -553,000 -542,000 -530,000 -517,000 -529,000 -411,000 -411,000 -432,000 -315,000 
      proceeds from exercise of stock options
    		412,000 1,755,000 719,000 3,445,000 239,000 240,000 1,676,000 745,000 1,292,000 702,000 3,392,000 764,000 502,000 646,000 820,000 1,969,000 2,702,000 3,197,000 1,758,000 2,086,000 557,000 360,000 152,000 
      net cash from financing activities
    		1,675,000 1,109,000 473,379,000 3,444,000 1,262,000 133,000 2,897,000 33,713,000 36,777,000 107,542,000 98,416,000 32,012,000 1,562,000 22,340,000 55,676,000 21,543,000 320,886,000 160,438,000 253,274,000 129,993,000 94,000 -779,000 193,014,000 
      net change in cash, cash equivalents and restricted cash
    		-14,149,000 -245,752,000 244,406,000 53,359,000 -62,165,000 4,617,000 -150,314,000 266,885,000 -63,237,000 -18,607,000 14,052,000 76,260,000 -109,108,000 -31,198,000 -263,173,000  400,008,000 114,774,000 -64,930,000  14,109,000 -748,000 88,829,000 
      cash, cash equivalents and restricted cash—beginning of period
    		0 0 290,111,000 0 0 0 444,614,000 0 0 0 245,521,000 0 0 0 572,740,000 0 0 0 177,011,000 0 0 0 50,553,000 
      cash, cash equivalents and restricted cash—end of period
    		-14,149,000 -245,752,000 534,517,000 53,359,000 -62,165,000 4,617,000 294,300,000 266,885,000 -63,237,000 -18,607,000 259,573,000 76,260,000 -109,108,000 -31,198,000 309,567,000 -54,123,000 400,008,000 114,774,000 112,081,000 24,268,000 14,109,000 -748,000 139,382,000 
      income from equity method investment
    		           0            
      amortization of operating lease right-of-use assets
    		                       
      other
    		           0 0 0 3,000 0 0 1,039,000 -976,000 0 0   
      collaboration receivable
    		           0 0 0 300,000,000         
      proceeds from issuance of common shares, net of commissions
    		       0 34,945,000 107,642,000 93,981,000 31,893,000 0 22,362,000 54,003,000 20,244,000 318,923,000       
      payment of equity offering costs
    		       0 -384,000 -185,000 -62,000 -54,000 -25,000 -103,000 -6,000  -209,000 -524,000 -7,955,000     
      equipment financings
    		                       
      proceeds from private stock issuance
    		                       
      amortization of investment (discount) premiums
    		                       
      other long-term assets
    		               0 0 -12,000 -185,000 -98,000 12,000 9,000 -77,000 
      net cash acquired from guide
    		               0 0 0 620,000     
      non-cash research and development license expense
    		                   487,000 4,900,000 0 264,000 
      purchase of non-controlling equity investment
    		                       
      proceeds from initial public offering, net of underwriting discount
    		                   0 0 0 192,510,000 
      proceeds from october 2020 public offering, net of underwriting discount
    		                       
      proceeds from equipment financings
    		                   1,642,000 0 0 1,625,000 
      financing milestone liabilities
    		                       
      proceeds from issuance of series b preferred stock
    		                       
      payment of initial and follow-on equity offering costs
    		                       
      net increase in cash, cash equivalents and restricted cash
    		                       
      purchase of long-term investment
    		                   0 0 0 -750,000 
      proceeds from offering of common stock
    		                  260,000,000     
      depreciation
    		                   1,272,000 1,218,000 1,145,000 1,100,000 
      payment of initial and follow-on public offering costs
    		                   -342,000    
      net increase in in cash, cash equivalents and restricted cash
    		                       
      amortization of investment premiums
    		                     25,000 -129,000 
      payment of initial public offering costs
    		                     -707,000 -958,000 
      supplemental disclosure of cash flow information:
    		                       
      cash paid for interest
    		                     148,000 134,000 
      supplemental disclosure of noncash investing and financing activities:
    		                       
      conversion of redeemable convertible preferred stock to common stock upon closing of the initial public offering
    		                     0 303,326,000 
      property and equipment additions in accounts payable and accrued expenses
    		                     -285,000 1,032,000 
      operating lease liabilities arising from obtaining right-of-use assets
    		                     1,763,000 4,032,000 
      receipt of common stock in exchange for technology license
    		                       
      issuance of common stock for research and development license
    		                       
      equity issuance costs in accounts payable and accrued expenses
    		                      707,000 
      accretion of redeemable convertible preferred stock to redemption value, including dividends on preferred stock
    		                     0 1,277,000 
      loss on issuance of preferred stock in connection with blink merger
    		                       
      loss on issuance of preferred stock to investors
    		                       
      change in fair value of preferred stock tranche liabilities
    		                       
      deferred rent liabilities
    		                       
      proceeds from issuance of series a-1 preferred stock
    		                       
      proceeds from issuance of series a-2 preferred stock
    		                       
      proceeds from issuance of blink series a preferred stock
    		                       
      equity issuance costs
    		                       
      issuance of common stock in connection with blink merger
    		                       
      issuance of common stock to founders in connection with blink merger
    		                       
      issuance of series a-2 preferred stock in connection with blink merger
    		                       
      issuance of series a-1 and a-2 preferred stock for research and development license
    		                       
      recognition and derecognition of preferred stock tranche liabilities
    		                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.